Rasgon Natalie L, Kenna Heather A, Wong Ma-Li, Whybrow Peter C, Bauer Michael
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305-5723, USA.
Psychoneuroendocrinology. 2007 Apr;32(3):279-86. doi: 10.1016/j.psyneuen.2006.12.014. Epub 2007 Feb 20.
Disturbance of each of the three hypothalamic-pituitary-end organ systems [hypothalamic-pituitary-thyroid (HPT), -adrenal (HPA), and -gonadal (HPG)] has been reported in depressive disorders. Little is known about potential reciprocal interaction among the three HP-end organ systems in patients with depressive disorders. The present pilot study examined selective HPA and HPG hormones in a detailed time series in women with bipolar disorder (depressed type) before and after treatment with levothyroxine (L-T4), and in matched control subjects. Six medically stable, euthyroid, premenopausal women with bipolar depression, and 5 age-matched controls underwent overnight blood sampling from 2100 to 0900 h for measurement of adrenocorticotropic hormone (ACTH), cortisol, luteinizing hormone (LH), and estradiol every 15 min. Bipolar patients underwent a second overnight blood sampling procedure following 7-weeks of open-label add-on treatment with L-T4. Results revealed lower baseline cortisol parameters in bipolar patients in comparison to control subjects, while ACTH, LH, and estradiol parameters were similar. Thyroid hormones (TSH, free and total T4) were not correlated with any of the HPA or HPG hormones. ACTH and cortisol levels were correlated in control subjects, but not in bipolar patients. After L-T4 treatment, thyroid hormones increased significantly and depression scores significantly declined. No significant changes in HPA or HPG hormones parameters were observed, although the small sample size may have limited results. Upon visual inspection, ACTH and cortisol appeared to decrease after L-T4 treatment, while estradiol appeared to increase. These pilot data suggest lower levels of cortisol in women with bipolar depression, unlike previously published studies that reported higher cortisol in patients with depression. The data also suggest reciprocal changes in the HPA and HPG axes upon pharmacological modulation of the HPT system, although whether this change was due to the L-T4 treatment or the improvement of depression is unknown. The results are preliminary, and require replication in larger samples.
据报道,抑郁症患者的下丘脑 - 垂体 - 终末器官系统(下丘脑 - 垂体 - 甲状腺(HPT)、 - 肾上腺(HPA)和 - 性腺(HPG))中的每一个都存在紊乱。关于抑郁症患者这三个下丘脑 - 垂体 - 终末器官系统之间潜在的相互作用,人们知之甚少。本初步研究在双相情感障碍(抑郁型)女性患者服用左甲状腺素(L - T4)治疗前后以及匹配的对照受试者中,对HPA和HPG激素进行了详细的时间序列研究。六名医学状况稳定、甲状腺功能正常、绝经前的双相抑郁症女性患者和五名年龄匹配的对照受试者在21:00至09:00期间进行了过夜采血,每15分钟测量一次促肾上腺皮质激素(ACTH)、皮质醇、黄体生成素(LH)和雌二醇。双相情感障碍患者在接受7周的L - T4开放标签附加治疗后进行了第二次过夜采血程序。结果显示,与对照受试者相比,双相情感障碍患者的基线皮质醇参数较低,而ACTH、LH和雌二醇参数相似。甲状腺激素(促甲状腺激素、游离和总T4)与任何HPA或HPG激素均无相关性。对照受试者中ACTH和皮质醇水平相关,但双相情感障碍患者中不相关。L - T4治疗后,甲状腺激素显著升高,抑郁评分显著下降。尽管样本量小可能限制了结果,但未观察到HPA或HPG激素参数有显著变化。经肉眼观察,L - T4治疗后ACTH和皮质醇似乎降低,而雌二醇似乎升高。这些初步数据表明,双相抑郁症女性患者的皮质醇水平较低,这与之前发表的报道抑郁症患者皮质醇水平较高的研究不同。数据还表明,在对HPT系统进行药理调节后,HPA和HPG轴会发生相互变化,尽管这种变化是由于L - T4治疗还是抑郁症的改善尚不清楚。这些结果是初步的,需要在更大样本中进行重复验证。